BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davies KA, Peters AM, Beynon HL, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest. 1992;90:2075-2083. [PMID: 1430231 DOI: 10.1172/jci116090] [Cited by in Crossref: 116] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Adekar SP, Segan AT, Chen C, Bermudez R, Elias MD, Selling BH, Kapadnis BP, Simpson LL, Simon PM, Dessain SK. Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein. PLoS One 2011;6:e17491. [PMID: 21399689 DOI: 10.1371/journal.pone.0017491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Davies KA, Schifferli JA, Walport MJ. Complement deficiency and immune complex disease. Springer Semin Immunopathol 1994;15:397-416. [PMID: 8153874 DOI: 10.1007/BF01837367] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
3 Jönsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 2004;6:R557-62. [PMID: 15535834 DOI: 10.1186/ar1224] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
4 Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, Adu D, Jolly EC, Watts R, Lau YL, Morgan AW, Nash G, Smith KG. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008;205:1573-82. [PMID: 18559452 DOI: 10.1084/jem.20072413] [Cited by in Crossref: 172] [Cited by in F6Publishing: 144] [Article Influence: 13.2] [Reference Citation Analysis]
5 Hepburn AL, Mason JC, Wang S, Shepherd CJ, Florey O, Haskard DO, Davies KA. Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol 2006;146:133-45. [PMID: 16968408 DOI: 10.1111/j.1365-2249.2006.03174.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
6 Clatworthy MR, Smith KG. B cells in glomerulonephritis: focus on lupus nephritis. Semin Immunopathol 2007;29:337-53. [PMID: 17943287 DOI: 10.1007/s00281-007-0092-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
7 Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, Padyukov L, Gunnarsson I, Svenungsson E, Savage CO, Watts RA, Lyons PA, Clayton DG, Smith KG. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010;19:3282-94. [PMID: 20508037 DOI: 10.1093/hmg/ddq216] [Cited by in Crossref: 102] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
8 Yuan H, Pan HF, Li LH, Feng JB, Li WX, Li XP, Ye DQ. Meta analysis on the association between FcgammaRIIa-R/H131 polymorphisms and systemic lupus erythematosus. Mol Biol Rep 2009;36:1053-8. [PMID: 18535921 DOI: 10.1007/s11033-008-9280-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
9 Birmingham DJ, Rovin BH, Yu CY, Hebert LA. Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res 2001;24:211-24. [PMID: 11594458 DOI: 10.1385/IR:24:2:211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bauer JW, Bilgic H, Baechler EC. Gene-expression profiling in rheumatic disease: tools and therapeutic potential. Nat Rev Rheumatol 2009;5:257-65. [PMID: 19412192 DOI: 10.1038/nrrheum.2009.50] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
11 Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017;23:5669-79. [PMID: 28883692 DOI: 10.3748/wjg.v23.i31.5669] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
12 Murota M, Nishioka M, Fujita J, Dobashi N, Wu F, Ohtsuki Y, Hojo S, Takahara J, Kuriyama S. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis. Clin Exp Immunol 2001;125:291-9. [PMID: 11529922 DOI: 10.1046/j.1365-2249.2001.01568.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nash JT, Taylor PR, Botto M, Norsworthy PJ, Davies KA, Walport MJ. Immune complex processing in C1q-deficient mice. Clin Exp Immunol 2001;123:196-202. [PMID: 11207648 DOI: 10.1046/j.1365-2249.2001.01459.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
14 Manger K, Repp R, Jansen M, Geisselbrecht M, Wassmuth R, Westerdaal NA, Pfahlberg A, Manger B, Kalden JR, van de Winkel JG. Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 2002;61:786-92. [PMID: 12176802 DOI: 10.1136/ard.61.9.786] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
15 Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b. Immunology. 2003;108:531-538. [PMID: 12667215 DOI: 10.1046/j.1365-2567.2003.01579.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
16 Ghiran IC, Zeidel ML, Shevkoplyas SS, Burns JM, Tsokos GC, Kyttaris VC. Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 2011;63:503-12. [PMID: 21280005 DOI: 10.1002/art.30143] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
17 Tonoli M, Davies KA, Norsworthy PJ, Cohen J, Walport MJ. The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35). Clin Exp Immunol 1993;92:232-8. [PMID: 8485908 DOI: 10.1111/j.1365-2249.1993.tb03385.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
18 Repik A, Pincus SE, Ghiran I, Nicholson-Weller A, Asher DR, Cerny AM, Casey LS, Jones SM, Jones SN, Mohamed N, Klickstein LB, Spitalny G, Finberg RW. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol 2005;140:230-40. [PMID: 15807846 DOI: 10.1111/j.1365-2249.2005.02764.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
19 Birmingham DJ, Gavit KF, McCarty SM, Yu CY, Rovin BH, Nagaraja HN, Hebert LA. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol 2006;143:274-80. [PMID: 16412051 DOI: 10.1111/j.1365-2249.2005.02983.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
20 Charles PJ. Defective waste disposal: does it induce autoantibodies in SLE? Ann Rheum Dis 2003;62:1-3. [PMID: 12480659 DOI: 10.1136/ard.62.1.1-a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
21 Sturfelt G, Truedsson L. Complement in the immunopathogenesis of rheumatic disease. Nat Rev Rheumatol 2012;8:458-68. [PMID: 22664835 DOI: 10.1038/nrrheum.2012.75] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
22 Crispín JC, Hedrich CM, Tsokos GC. Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 2013;9:476-84. [PMID: 23732569 DOI: 10.1038/nrrheum.2013.78] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
23 D’Arrigo C, Candal-Couto JJ, Greer M, Veale DJ, Woof JM. Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest. Clin Exp Immunol. 1995;100:173-179. [PMID: 7535210 DOI: 10.1111/j.1365-2249.1995.tb03620.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 1.7] [Reference Citation Analysis]
24 Punyadee N, Mairiang D, Thiemmeca S, Komoltri C, Pan-Ngum W, Chomanee N, Charngkaew K, Tangthawornchaikul N, Limpitikul W, Vasanawathana S, Malasit P, Avirutnan P. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection. J Virol 2015;89:1587-607. [PMID: 25410854 DOI: 10.1128/JVI.02207-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
25 Vandendriessche S, Cambier S, Proost P, Marques PE. Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis. Front Cell Dev Biol 2021;9:624025. [PMID: 33644062 DOI: 10.3389/fcell.2021.624025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
26 Belstrøm D, Holmstrup P, Damgaard C, Borch TS, Skjødt MO, Bendtzen K, Nielsen CH. The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes. Infect Immun 2011;79:1559-65. [PMID: 21245264 DOI: 10.1128/IAI.01036-10] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
27 Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016;14:35. [PMID: 27260006 DOI: 10.1186/s12969-016-0094-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]